Molecular Biology
Global

Molecular Biology Experts

Dr. David Morris

Member
BOD
Inflazome
Ireland

Biography

Dave joined Novartis in Basel in 2009 to develop new medicines for patients with serious medical conditions. From 2010-2014, he was the Development Franchise head for Respiratory and Primary Care where he and his team were responsible for the clinical development, regulatory approvals and lifecycle management of multiple Novartis medications including new treatments for serious respiratory diseases (COPD, asthma, pulmonary hypertension), diabetes, and hypertension. In June, 2014, he was appointed the Global Head of Clinical Operations, Analytics and Regions with overall responsibility for global clinical operations, quantitative sciences, digital innovation, development informatics, and global clinical research capabilities development for Novartis Global Drug Development. In September, 2016, he moved over to the Novartis Venture Fund to leverage his basic and clinical scientific background and operational experience to better speed the discovery and development of new medicines by working closely with external entrepreneurs and venture backed start-ups. Dave received his Bachelor of Sciences with honors in Neurosciences and his MD with honors in research from the University of Rochester in the US. His clinical training in internal medicine was at the Massachusetts General Hospital followed by a fellowship in Pulmonary and Critical Care Medicine at the University of California, San Francisco. He was subsequently a faculty member at UCSF and, thereafter, Yale University where he led the interstitial lung disease clinical and research units. His research work in respiratory cell and molecular biology, immunology and translational sciences was at the National Institutes of Health, the UCSF Cardiovascular Research Institute, the Lung Biology Center and Yale University School of Medicine. Prior to joining Novartis, Dave led the respiratory research and then translational medicine groups at Roche in Palo Alto, California. His basic and clinical research work has been published in Nature, PNAS, Journal of Immunology, and AJRCCM among others. He has contributed to several major textbooks of respiratory medicine in the areas of interstitial lung diseases and the genetics of lung diseases.

Research Interest

product development , biotechnology , Business management

Global Experts from Ireland

Global Experts in Subject

Share This Profile
Recommended Conferences